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Retinoic Acid Increases Aquaporin 3 Expression
in Normal Human Skin
Gaelle Belleme`re1, Otto Von Stetten1 and Thierry Oddos1
We have investigated the effects of all-trans retinoic acid (ATRA) on aquaporin 3 (AQP3) expression and function
both in vitro and ex vivo. ATRA treatment provoked a rapid accumulation of AQP3 transcripts in cultured normal
human epidermal keratinocytes (NHEK). This increase was still observed 24hours after application of ATRA. The
induction of AQP3 gene was accompanied by an augmentation of immunoreactivity. Using a selective agonist,
we demonstrated that the effect of ATRA was predominantly mediated by retinoic acid receptor subtype g
(RARg). Incubation of NHEK in ATRA for 24, 48, and 72 hours stimulated glycerol influx, suggesting that the
increase in AQP3 gene and protein expression was followed by an enhancement of biological activity. Topical
application of ATRA for 24 hours on skin explants induced significant epidermal expression of AQP3 and strong
immunoreactivity in the epidermal basal layers. Collectively, the present results show that ATRA increased AQP3
expression and enhanced biological activity in human skin.
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INTRODUCTION
All-trans retinoic acid (ATRA) and its derivatives, commonly
called retinoids, are important regulators of several biological
processes, such as embryogenesis, reproduction, differentia-
tion, proliferation, and apoptosis (Ahuja et al., 2003; Wilson
et al., 2003). Retinoids exert potent keratolytic effects in skin
and are frequently prescribed in severe forms of psoriasis
(Smit et al., 2004). Retinoids inhibit sebocyte proliferation
and differentiation and are of therapeutic value for the
treatment of acne vulgaris (Gollnick, 2003). Retinoids are also
potent stimulators of keratinocyte proliferation (Fisher and
Voorhees, 1996) through the release of heparin-binding
epidermal growth factor produced by suprabasal keratinocytes
(Chapellier et al., 2002). Retinoids also inhibit the expression of
key genes involved in keratinocyte differentiation such as
caspase 14 or differentiation-specific keratins (van Rossum
et al., 2000; Rendl et al., 2002). By regulating keratinocyte
proliferation and differentiation, retinoids increase stratum
granulosum thickness and are widely used in cosmetics for the
treatment of skin aging (Varani et al., 2000; Roeder et al., 2004).
Water channel aquaporin 3 (AQP3) is a member of a
subgroup of the aquaporin family, called aquaglyceroporins,
which transports both water and small neutral solutes, such
as glycerol. AQP3 was first cloned from rat kidney (Sasaki
et al., 1994) and subsequently found in red blood cells
(Roudier et al., 1998), chondrocytes (Mobasheri et al., 2004),
and in epithelial cells from the urinary, digestive, and
respiratory systems (Frigeri et al., 1995; Nielsen et al.,
1997; Koyama et al., 1999; Matsuzaki et al., 1999). In skin,
AQP3 is constitutively expressed by epidermal keratinocytes
(Sougrat et al., 2002). AQP3-deficient mice suffer from
reduced water and glycerol permeabilities and decreased
water holding capacity of the stratum corneum, demonstrat-
ing a pivotal role of this channel in the maintenance of skin
hydration (Ma et al., 2002). AQP3-deficient mice also show
delayed barrier recovery following tape-stripping disruption
together with delayed wound healing, suggesting a possible
involvement of AQP3 in the regulation of keratinocyte
differentiation and proliferation (Hara et al., 2002). In support
of this hypothesis, it has been demonstrated that AQP3 is
downregulated by differentiating agents such as high calcium
concentrations and 1,25-dihydroxyvitamin D3 (Zheng and
Bollinger Bollag, 2003).
In this study, we investigated whether ATRA, a potent
modulator of keratinocyte proliferation and differentiation,
can regulate AQP3 expression, tissue distribution, and
biological activity.
RESULTS
AQP3 is the most abundant AQP in the skin
The subtypes of AQPs expressed in normal human epidermal
keratinocytes (NHEK) and in human epidermis were identi-
fied using reverse transcription-PCR with AQP1-9-specific
primers (S1). NHEK expressed mainly AQP3 transcripts
(Figure 1a). A faint band corresponding to AQP9 was also
detected in NHEK (Figure 1a). In contrast, in human
epidermis, a single band corresponding to AQP3 was
visualized (Figure 1b).
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ATRA is increasing AQP3 expression in NHEK through RARc
NHEK were treated with 1 mM ATRA. Cells were collected
after 0.5, 1, 2, 3, 24, and 48 hours of incubation and the effect
of ATRA on gene expression was determined by means of
real-time quantitative PCR (rtQPCR). Application of 1 mM
ATRA significantly increased AQP3 gene expression
(þ 214%) after 2 hours (Figure 2). A significant accumulation
of AQP3 transcripts was also noted after 3 hours (þ 112%)
and 24 hours (þ148%) of incubation (Figure 2). After
48 hours of incubation, the expression of AQP3 returned to
control levels.
NHEK were exposed to several concentrations of ATRA
ranging from 0.1 to 10 mM to test the dose dependency for the
AQP3 expression. Application of increasing concentrations of
ATRA produced a significant increase in the level of
AQP3 transcripts (þ241% for 5 mM and þ494% for 10 mM,
Figure 3a). To identify which retinoic acid receptor (RAR) is
involved in the effect of ATRA on NHEK, the cells were
exposed to several concentrations of the specific RARa
agonist, Am580 and the specific RARg agonist, CD437.
Application of CD437 enhanced AQP3 mRNA expression in
Figure 1. AQP3 is the most abundant AQP in the skin. PCR analysis of AQP
expression patterns was performed in (a) cultured NHEK and (b) in human
epidermis (b). One microgram RNA was reverse transcribed into first-strand
cDNA and amplified by PCR using AQP (A1–9)-specific primers. As a control,
PCR was performed using b-actin (act)-specific primers.
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Figure 2. ATRA is time-dependently increasing AQP3 gene expression in
cultured NHEK. The time course effect of ATRA on AQP3 expression in NHEK
was analyzed by rtQPCR analysis. The cells were seeded in 25-cm2 flasks and
cultured until they reached 80% confluence. They were then treated with
1mM ATRA for incubation times ranging from 0.5 to 48 hours. At the
indicated times, the cells were pelleted and RNA was extracted. One
microgram RNA was reverse transcribed into first-strand cDNA and
rtQPCR was performed using AQP3-specific primers. The expression levels of
AQP3 mRNA were normalized using the actin expression to correct for RNA
quantity and integrity. Data are expressed as percentage of the corresponding
control for each time point and are presented as mean7SEM (n¼ 5).
*Po0.05; **Po0.01 vs corresponding control. CTL, control.
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Figure 3. The effect of ATRA on AQP3 gene expression mainly involves
RARc receptors. The effects of increasing concentrations of (a) ATRA,
(b) RARg agonist CD437, and (c) RARa agonist Am580 on AQP3 expression
were investigated by rtQPCR. Cells were seeded in 25-cm2 flasks and cultured
until they reached 80% confluence at passage 1. They were then treated with
ATRA, CD437, or Am580 at concentrations ranging from 0.1 to 10 mM for
24 hours. At the end of incubation, the cells were pelleted and RNA was
extracted. One microgram RNA was reverse transcribed into first-strand
cDNA and rtQPCR was performed using AQP3-specific primers. The
expression levels of AQP3 mRNA were normalized using the actin expression
to correct for RNA quantity and integrity. Data are expressed as percentage of
untreated control and are presented as mean7SEM (n¼3). *Po0.05,
**Po0.01 vs untreated control.
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a dose-dependent manner (þ445% for 5 mM, Figure 3b). In
contrast, Am580 at concentrations ranging from 0.1 to 5 mM
produced a limited and non significant increase in AQP3
gene expression (Figure 3c).
ATRA is increasing AQP3 protein expression in NHEK
To analyze the ATRA effect on the AQP3 protein, cultured
NHEK were treated with ATRA at three concentrations (0.1,
1, and 10 mM) for 3, 24, and 48 hours. Proteins were extracted
from pelleted cells under non-reducing conditions and
subjected to analysis by SDS-PAGE followed by Western
blot. AQP3 antiserum revealed the presence of two bands
exhibiting apparent molecular weights of 28 kDa (Figure 4a)
and 40 kDa (not shown). These data are in good agreement
with previous studies reporting that antisera directed against
the C-terminal end of the protein recognize both unglycosy-
lated (30 kDa) and glycosylated (40 kDa) forms of AQP3
(Ishibashi et al., 1994). Our results also show that 3-hour
application of ATRA at concentrations of 1 and 10 mM
provoked an accumulation of AQP3-immunoreactive mate-
rial, whereas treatment with ATRA at the lowest concentra-
tion did not show any effect (Figure 4a). Application of ATRA
for 24 and 48 hours did not increase the amount of 28-kDa
immunoreactive material (Figure 4a). These results were
confirmed by densitometric analysis of the signals generated
after two independent experiments, which revealed that
AQP3 immunoreactive protein significantly accumulated
after treatment by 1 and 10 mM ATRA for 3 hours (þ101
and þ131% respectively, Figure 4b).
ATRA is stimulating glycerol uptake in NHEK
The noted increase in AQP3 gene and protein expression
induced by ATRA may also modulate cellular transport
processes. It has been shown that AQP3 is a glycerol-permeable
channel. We have therefore investigated the effects of ATRA
on glycerol uptake. NHEK were incubated in culture medium
containing 1mM ATRA for 3, 24, 48, and 72 hours before
glycerol transport was measured. When NHEK were treated
for 3 hours with ATRA, the [3H]glycerol amount detected in
treated cells was not significantly different from that of
untreated cells (Figure 5). In contrast when longer incuba-
tions of NHEK in ATRA were performed, glycerol uptake was
significantly stimulated (þ 30, þ 50, and þ 48%, 24-, 48-,
and 72-hour incubations respectively, Figure 5).
ATRA is increasing AQP3 expression in human skin explants
An oil-in-water carbopol-based emulsion containing 0.05%
ATRA was applied topically on skin explants for 3 and
24 hours. The epidermis was collected and further processed
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Figure 4. ATRA is stimulating AQP3 protein accumulation in cultured NHEK. The effects of ATRA on AQP3 protein were analyzed by Western blot.
The cells were treated with ATRA (0.1–10 mM) for 3, 24, and 48 hours. At the end of incubation, the cells were pelleted and proteins were extracted.
The protein extracts were subjected to electrophoresis, transferred to polyvinyldifluoride membranes, and incubated with anti-AQP3 or anti-b-actin antibodies.
(a) The antibody against AQP3 revealed a major band migrating at 30 kDa. (b) The immunostaining levels of the 30-kDa band were compared in each
condition by densitometric quantification and were expressed as a ratio of b-actin immunoreactive signal. Data are expressed as percentage of untreated
control and are presented as mean7SEM (n¼ 2). *Po0.05, **Po0.01 vs untreated control. CTL, control.
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Figure 5. ATRA is enhancing glycerol uptake by cultured NHEK. Cultured
NHEK were treated with ATRA (10 mM) for 3, 24, 48, and 72 hours. At the
indicated times, the medium was replaced by freshly prepared buffer
containing 1 mCi [3H]glycerol. After a 5-minute incubation, the radioactivity
of cell lysates was counted. Data are presented as mean7SEM (n¼ 3).
*Po0.05; **Po0.01, ***Po0.001 vs corresponding control. CTL, control.
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for rtQPCR. Application of the placebo emulsion for 3 hours
did not modify AQP3 gene expression in the epidermis
(Figure 6a). Formulated ATRA induced a limited and
not significant increase in mRNA levels at 3 hours (þ 67%,
Figure 6a). In contrast, a marked increase in AQP3 mRNA
was observed when skin explants were treated for 24 hours
(þ 95%, Figure 6b).
The effect of ATRA-containing emulsion on AQP3 protein
expression was also investigated in skin explants by
immunohistochemistry. As confirmed by Masson Trichrome
histological staining, incubation of skin explants for 48 hours
in maintenance medium under a 5% CO2 humidified
atmosphere did not affect tissue integrity (Figure 7a–c). Under
control conditions, AQP3 antiserum stained exclusively the
viable cells of the epidermis (except from the stratum
granulosum) and the labeling was typically concentrated on
the plasma membrane (Figure 7d, f, and h). It is noteworthy
that AQP3 immunoreactivity is more abundant in the basal
layers than in the upper layers of the epidermis (Figure 7d, f,
and h). No variation in staining intensity was observed during
the course of the treatment, indicating that incubation of skin
explants for 48 hours did not alter AQP3 immunoreactivity
(Figure 7d, f, and h).
Application of 0.05 % ATRA for 3 hours did not provoke
any visible variation in staining intensity and did not modify
AQP3 localization in the epidermis (Figure 7e). Similarly,
when ATRA was applied for 24 hours, no modification in
AQP3 immunoreactivity could be observed (Figure 7g). In
contrast, when explants were treated by 0.05% ATRA for
48 hours, an increase in staining intensity was visualized
within all the epidermal layers. In addition, basal layers of the
epidermis exhibited a remarkable intracellular labeling,
suggesting that newly synthesized AQP3 may accumulate
in the cytoplasm of the basal cells (Figure 7i).
DISCUSSION
AQPs are water channels present in many organs and tissues.
AQP3 is the most abundant AQP in human epidermis
(Sougrat et al., 2002). In this study, we have investigated
the effect of ATRA, a known regulator of keratinocyte
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Figure 6. ATRA is increasing AQP3 gene expression in human skin explants.
The effects of ATRA on AQP3 expression in human epidermis were
investigated by rtQPCR. Explants were punched from skin biopsies and
cultured in maintenance medium overnight. Five microliters of ATRA-
containing emulsion were applied on skin explants for (a) 3 hours and
(b) 24 hours. At the indicated times RNA was extracted from epidermises.
One microgram RNA was reverse transcribed into first-strand cDNA and
rtQPCR was performed using AQP3-specific primers. The expression levels
of AQP3 mRNA were normalized using the actin expression to correct for
RNA quantity and integrity. Data are expressed as percentage of control
(control 3 hours¼ 100%) and are presented as mean7SEM (n¼ 4).
***Po0.001 vs control 3 hours. CTL, control.
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Figure 7. Topical application of ATRA-containing emulsion is inducing an
accumulation of AQP3 immunoreactivity in human skin explants.
To visualize the tissue integrity, untreated skin sections were stained
using Masson Trichrome (a–c). Skin explants were treated with 5 ml of
placebo (d, f, h) or ATRA-containing emulsion (e, g, i) for 3 hours
(d, e), 24 hours (f, g), and 48hours (h, i). Skin sections were immunostained
by rabbit antiserum directed against AQP3 (d–i). Bar¼ 50mm.
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proliferation and differentiation, on AQP3 expression and
function. Our results show that application of micromolar
concentrations of ATRA to NHEK for up to 24 hours induced
a strong increase in AQP3 gene expression presumably
through activation of RARg receptor. Concomitantly, ATRA
produced a rapid accumulation of 28-kDa immunoreactive
form of AQP3. When applied topically on human skin, ATRA
induced an overexpression of AQP3 both at the gene and
protein levels. Using the tritiated glycerol uptake assay, we
finally demonstrated that the increase in AQP3 expression
was accompanied by a stimulation of glycerol uptake,
suggesting that the increase in AQP3 expression was
translated in functional enhancement of cellular transport.
Whereas ATRA provoked a long-lasting stimulation of AQP3
gene expression for up to 24 hours, we could not detect by
Western blot any accumulation of AQP3 immunoreactivity in
NHEK after 24 hours of incubation, although a strong
increase in 28-kDa immunoreactive staining was observed
after 3 hours of treatment. Molecular analysis of AQPs has
shown that these proteins are based on tetrameric arrange-
ments of four channels that stick together within the cell
membrane and that appear to be resistant to detergent-based
purification (Smith and Agre, 1991; Stroud et al., 2003).
AQP3 antibodies directed against the C-terminal end of
AQP3 monomer can detect preferentially both glycosylated
and unglycosylated monomeric forms of the protein (Ishiba-
shi et al., 1994). The fact that we did not observe any effect of
ATRA on 28-kDa AQP3 protein after 24 hours of incubation
might suggest that newly synthesized AQP3 monomers do
not accumulate into the cytoplasm and are rapidly trans-
formed in tetramers that were not fully extracted in our
Western blot procedure. In support of this hypothesis,
Ecelbarger et al. (1995) have demonstrated by immunoelec-
tron microscopy that AQP3 is mainly located at the
membrane compartment with little or no staining in
intracellular vesicles, suggesting that this protein rapidly
transits from Golgi apparatus to the cell membrane. Alter-
natively, we could not rule out the possibility that acute post-
transcriptional regulation of AQP3 may occur in NHEK and
that the increase in AQP3 transcripts was not translated into
proteins. On the other hand, our functional assay demons-
trated that ATRA significantly enhanced tritiated glycerol
uptake after 24 hours of incubation and that the stimulation of
glycerol transport was still noted after 48 and 72 hours of
incubation. These data strongly suggest that the AQP3-
specific glycerol transport was actually stimulated, most
likely through increased AQP3 expression.
In skin explants, we have shown that ATRA induced AQP3
mRNA expression 24 hours after topical application and we
have demonstrated by immunohistochemistry that AQP3 is
visibly overexpressed 48 hours after the application of ATRA-
containing gel. Retinoids and other active molecules may
take long time to exert an effect in skin, compared with the
rapid onset of the same effect in cell cultures. For instance,
although heparin-binding epidermal growth factor expression
is stimulated by ATRA in NHEK as early as 3 hours after
application (personal observation, Yoshimura et al., 2003), it
has been shown that in human skin maximal induction of
heparin-binding epidermal growth factor was obtained
24 hours following application of 0.1% ATRA (Rittie
et al., 2006).
Representing about 90% of the RARs expressed in the
epidermis (Fisher and Voorhees, 1996), RARg is mediating
most of the effects of ATRA, such as keratinocyte growth in
normal skin or antihyperproliferation in non-melanoma skin
cancers (Fisher and Voorhees, 1996; Papoutsaki et al., 2004).
By using the RARa- and RARg-specific agonists, Am580 and
CD437, we have determined that predominantly CD437
could significantly increase AQP3 transcripts, whereas
Am580 did not show any effect. This may designate RARg
as the main receptor involved in the effects of ATRA on AQP3
expression. However, it has been shown that CD437 can
induce apoptosis in human squamous cell carcinoma cells
and that this effect is not abolished by the RAR antagonist,
indicating that CD437 is able to induce RAR-independent
effects (Sun et al., 2000). Further studies are therefore needed
to determine whether CD437 is acting directly via RARg.
AQP3-deficient mice show delayed barrier recovery after
tape-stripping disruption and delayed wound healing (Hara
et al., 2002), suggesting a possible involvement of AQP3 in
the regulation of keratinocyte differentiation and prolifera-
tion. In fact, AQP3 expression is downregulated by differ-
entiating agents, such as high Ca2þ concentrations and 1,25
dihydroxyvitamin D3 (Zheng and Bollinger Bollag, 2003).
Here, we demonstrated that AQP3 expression and biological
activity were stimulated by ATRA, a known inducer of
keratinocyte proliferation. These data suggest that AQP3 is
finely regulated during epidermal differentiation. However,
the physiological role of this channel in epidermal maturation
remains unclear. Previous studies have reported that AQP3
colocates with phospholipase D2 in caveolin-rich membrane
microdomains and it has been assumed that AQP3 may
provide glycerol to phospholipase D2 to generate phospha-
tidylglycerol, which in turn might initiate early differentiation
(Zheng and Bollinger Bollag, 2003). The finding that retinoids
increase AQP3 expression and stimulate glycerol transport
further confirms that, beyond its humectant properties,
glycerol may actually play a biological role in epidermal
maturation.
In conclusion, we have demonstrated that ATRA stimu-
lated AQP3 gene and protein expression in NHEK as well as
in skin explants and increased glycerol transport capacity,
indicating that stimulation of AQP3 expression was accom-
panied by an enhancement of biological activity. Over-
expression of functional AQP3 may increase skin glycerol
content, which in turn may be a key messenger of
keratinocyte proliferation and early differentiation processes.
MATERIALS AND METHODS
Preparation of skin explants and keratinocyte primary cultures
Abdominal skin samples were obtained from normal human adults
undergoing plastic surgery. For the ex vivo experiments, 0.93-cm2
biopsies were punched in skin samples under sterile conditions and
placed in maintenance medium under a 5% CO2 humidified
atmosphere overnight until treatment. Skin biopsies taken from three
to five individuals were used in each experiment. For the in vivo
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experiments, NHEK were dissociated by enzymatic and mechanical
dispersion and seeded at a density of 40 000 cells/cm2 in KGM-2
(Cambrex Bio Science Paris, Emerainville, France) containing an
antifungal solution.
This study was conducted in accordance with the Declaration of
Helsinki Principles and was approved by Johnson & Johnson
consumer R&D Board. Informed consent was obtained from each
patient.
Chemicals and treatments
ATRA, the RARa analogue Am580, and the RARg analogue CD437
were obtained from Sigma (St Louis, MO).
For the in vitro agonist studies stock solutions of ATRA, Am580,
and CD437 (10mM) were prepared in DMSO and subsequent
dilutions were made in culture medium, so that the final concentra-
tion of DMSO was always 0.1%. Concentrations of ATRA, CD437,
and Am580 ranging from 0.1 to 10 mM were applied on NHEK for
24 hours. For the study of kinetics, 1 mM ATRA was applied on NHEK
for 0.5, 1, 2, 3, 24, and 48 hours. At the end of the treatment, the
cells were rinsed in phosphate-buffered saline, pelleted, and stored
at 801C until further assayed.
For the ex vivo treatments, skin biopsies were treated by topical
application of ATRA formulated at a concentration of 0.05% in an
oil-in-water emulsion containing carbopol gel. Five microliters were
applied onto skin explants and application was repeated after
24 hours of incubation. A placebo emulsion was prepared as a
control and applied onto skin following the same procedure. Skin
explants were collected after 3, 24, and 48hours of incubation. For
the rtQPCR analysis of AQP3 gene expression, the epidermis was
separated from the dermis by heat. The samples were further
homogenized in TriReagent (Sigma, Saint-Quentin Fallavier, France)
and kept at 801C until RNA extraction. For the analysis of protein
expression and localization, skin explants were collected, frozen on
dry ice, and kept at 801C until immunohistochemistry.
RNA extraction
The total RNA from NHEK pellets was extracted using the SV total
RNA Isolation System (Promega, Charbonnie`res, France) following
the manufacturer’s instructions. RNA from skin explants was
extracted by the acid guanidium–thiocyanate–phenol–chloroform
method using TriReagent. The concentration of total RNA was
determined by measuring the optical density at 260 nm.
Reverse transcription and PCR
One microgram of total RNA was converted into first-strand cDNA
using the ImProm-II Reverse Transcription system with either
Oligo(dT)15 primers (semiquantitative PCR) or random primers
(rtQPCR), as suggested by the manufacturer’s instructions (Promega).
Parallel reactions for each RNA sample were run in the absence
of reverse transcriptase to assess any genomic DNA contamination of
the RNA.
For the semiquantitative PCR experiment, the reverse transcrip-
tion product was amplified using specific primers (Proligo, Paris,
France) designed from human AQPs 1-9 cDNAs and the b-actin
cDNA. The amplified PCR products were subjected to electrophor-
esis on 1.5% agarose gel and visualized on a UV table.
The rtQPCR experiments were carried out in an M3000 p
detection system (Stratagene, Amsterdam, The Netherlands) using a
SYBR Green PCR Mastermix (Stratagene). Each sample was analyzed
in duplicate along with standard and no-template controls. The
reaction contained 30 ng cDNA in 1 Mastermix, including pre-set
concentrations of deoxyribonucleotide triphosphates, MgCl2, and
buffers, along with 300 nM forward and reverse primers and the SYBR
Green reporter dye. The PCR parameters were 951C for 10minutes,
40 cycles at 951C for 15 seconds, 601C for 1minute, and 721C for
30 seconds. RNA concentrations were determined by comparing
cDNA-generated signals in samples with those generated from
known amounts of cDNA. RNA levels were corrected with the b-
actin cDNA signal for variations in amounts of input RNA. Product
purity was confirmed using a dissociation standard curve and
agarose gel electrophoresis. Primers were designed from the human
AQP3 cDNA and b-actin cDNA using the Beacon Designer 3.01
software (Premier Biosoft International, Palo Alto, CA): AQP3
forward primer, 50-ACCTTTGCCATGTGCTTCCT-30 AQP3 reverse
primer, 50-GCGTCTGTGCCAGGGTGTA-30 b-actin forward primer,
50-CTGGCACCCAGCACAATG-30; b-actin reverse primer, 50-GCC
GATCCACACGGAGTACT-30 (Proligo).
Immunohistochemistry
Skin explant sections (7-mm thick) were cut in a cryomicrotome
(2800 Frigocut; Leica, Heidelberg, Germany) and collected on 3-
aminopropyltriethoxysilane-coated glass slides. After fixation in
acetone, the sections were incubated for 1 hour in phosphate-
buffered saline containing 0.3% BSA and rabbit anti-AQP3
antiserum diluted 1:500 (Chemicon International, Paris, France).
Skin sections were rinsed in phosphate-buffered saline and
incubated for 1 hour in the presence of biotinylated goat anti-rabbit
Igs diluted 1:2500 (Zymed Laboratories, CliniSciences, Montrouge,
France). Reaction products were detected by FITC-conjugated
streptavidin diluted 1:1250 (Caltag Laboratories, Burlingame, CA).
Finally, sections were counterstained with propidium iodide,
mounted in Fluoprep (Biome´rieux, Marcy l’Etoile, France), covered,
and stored in the dark at 41C. The integrity of the explants was
assessed by Masson Trichrome histological staining.
SDS-PAGE and Western blot analysis
Proteins were analyzed by PAGE under non-reducing conditions and
electroblotted onto polyvinyldifluoride membranes (Millipore, Mol-
sheim, France). The membranes were incubated for 2 hours with
AQP3 antibodies diluted 1:200 (Calbiochem, Nottingham, UK) or
actin antibodies diluted 1:1000 (Calbiochem) in 0.1 M Tris-buffered
saline containing 5% non-fat dry milk and 0.05% Tween 20. The
membranes were then rinsed in Tris-buffered saline /non-fat dry
milk/Tween 20 and incubated for 1 hour with horseradish perox-
idase-conjugated goat anti-rabbit Igs diluted 1:2000 (Interchim,
Montluc¸on, France). Finally, the membranes were rinsed in Tris-
buffered saline and the reaction product was detected by using a
chemiluminescence detection kit (Amersham Biosciences, Freiburg,
Germany). The resulting signals were analyzed by densitometry and
the results were expressed as the ratio of the optical density of the
AQP3-corresponding band to that of actin.
Tritiated glycerol uptake
NHEK were grown in 12-well plates and treated by 10 mM ATRA for
3, 24, 48, and 72 hours as indicated above. At the end of the
treatment, the cells were incubated for 5minutes in KGM-2
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containing 0.1 M N-2-hydroxyethylpiperazine-N0-2-ethanesulphonic
acid and 1 mCi [3H]glycerol (Amersham Biosciences). The medium
was then removed and the cells were rinsed three times in cold
phosphate-buffered saline and lysed in 0.3M NaOH. The radio-
activity of the cell lysates was counted by a b-counter (Wallac
Tricarb, Packard, Schwadorf, Austria).
Statistical analysis
Results are expressed as means7SEM. For comparisons, the
Student’s t-test was performed and statistical significance was
considered for Po0.05. Statistical analysis was performed using
GraphPad software.
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